DEFA5 and Alzheimer disease: For instance, using CD4+ IELs from DEFA5 knockout mice or adoptively transferring CD4+ T cell populations incapable of producing DEFA5 as control groups would help further elucidate the specific contribution of DEFA5 to AD-associated intestinal inflammation.